The newsroom

Research & news

Follow the research, the regulatory record and the people building the peptide industry. Each entry identifies whether you are reading onsite coverage or a link to an outside source.

1 publication

Regulatory· Source link

Jesse Dresser Featured in Forbes: “Peptides May Soon Be Legal. These Companies Are Ready To Cash In”

The FDAs review of seven peptides has sparked significant interest across the healthcare industry, with compounding pharmacies, telehealth companies, investors, and other market participants preparing for the possibility of expanded legal access to peptide compounding. As federal regulators conside…

Frier LevittJul 23, 2026